Yohannes Tesfaigzi

10.7k total citations · 2 hit papers
161 papers, 5.8k citations indexed

About

Yohannes Tesfaigzi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Yohannes Tesfaigzi has authored 161 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 53 papers in Molecular Biology and 45 papers in Physiology. Recurrent topics in Yohannes Tesfaigzi's work include Chronic Obstructive Pulmonary Disease (COPD) Research (45 papers), Asthma and respiratory diseases (34 papers) and Neonatal Respiratory Health Research (25 papers). Yohannes Tesfaigzi is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (45 papers), Asthma and respiratory diseases (34 papers) and Neonatal Respiratory Health Research (25 papers). Yohannes Tesfaigzi collaborates with scholars based in United States, Italy and Canada. Yohannes Tesfaigzi's co-authors include Yohannes A. Mebratu, Hans Petersen, Steven A. Belinsky, Anil K. Sood, Paula Meek, Bartolomé R. Celli, Caroline A. Owen, Don M. Carlson, Víctor Pinto-Plata and Miguel Divo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yohannes Tesfaigzi

159 papers receiving 5.7k citations

Hit Papers

How ERK1/2 activation controls cell proliferation and cel... 2009 2026 2014 2020 2009 2015 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?
    2009 779 citations Yohannes A. Mebratu, Yohannes Tesfaigzi profile →
  2. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
    2015 739 citations Bartolomé R. Celli, Miguel Divo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohannes Tesfaigzi United States 39 2.2k 2.0k 1.2k 751 648 161 5.8k
Kenneth B. Adler United States 44 2.1k 0.9× 1.6k 0.8× 1.2k 1.0× 583 0.8× 850 1.3× 150 5.3k
H. Marike Boezen Netherlands 45 2.6k 1.2× 1.4k 0.7× 1.4k 1.2× 683 0.9× 557 0.9× 166 6.4k
Debra J. Romberger United States 40 2.1k 1.0× 1.1k 0.6× 1.3k 1.1× 1.1k 1.5× 941 1.5× 186 5.8k
George D. Leikauf United States 49 2.4k 1.1× 2.2k 1.1× 1.9k 1.6× 1.5k 2.0× 1.1k 1.6× 143 7.4k
Thomas J. Mariani United States 41 2.3k 1.0× 2.4k 1.2× 1.0k 0.9× 427 0.6× 949 1.5× 130 6.5k
Irene H. Heijink Netherlands 43 2.3k 1.0× 1.7k 0.9× 1.7k 1.4× 355 0.5× 1.2k 1.8× 155 5.3k
Shizu Hayashi Canada 36 2.4k 1.1× 1.8k 0.9× 1.2k 1.0× 622 0.8× 683 1.1× 84 5.4k
Matthias Salathé United States 43 2.7k 1.2× 1.6k 0.8× 1.6k 1.3× 407 0.5× 669 1.0× 145 6.2k
Tim D. Oury United States 55 3.0k 1.4× 3.2k 1.6× 1.8k 1.5× 443 0.6× 1.1k 1.7× 139 9.6k
Todd A. Wyatt United States 42 1.6k 0.7× 1.5k 0.8× 1.1k 1.0× 640 0.9× 813 1.3× 208 5.4k

Countries citing papers authored by Yohannes Tesfaigzi

Since Specialization
Citations

This map shows the geographic impact of Yohannes Tesfaigzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohannes Tesfaigzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohannes Tesfaigzi more than expected).

Fields of papers citing papers by Yohannes Tesfaigzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohannes Tesfaigzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohannes Tesfaigzi. The network helps show where Yohannes Tesfaigzi may publish in the future.

Co-authorship network of co-authors of Yohannes Tesfaigzi

This figure shows the co-authorship network connecting the top 25 collaborators of Yohannes Tesfaigzi. A scholar is included among the top collaborators of Yohannes Tesfaigzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohannes Tesfaigzi. Yohannes Tesfaigzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soni, Sourabh, Soner Yildiz, E. Kaitlynn Allen, et al.. (2025). BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza. Proceedings of the National Academy of Sciences. 122(28). e2424367122–e2424367122. 1 indexed citations
2.
Tesfaigzi, Yohannes, et al.. (2024). Persistence of emphysema following cessation of cigarette smoke exposure requires a susceptibility factor. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(4). L431–L439.
3.
Rojas, Joselyn, María Laucho-Contreras, Xiaoyun Wang, et al.. (2023). CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice. JCI Insight. 8(6). 8 indexed citations
4.
Wang, Xiaoyun, Joselyn Rojas, Julie A. Wilder, et al.. (2019). Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces. The Journal of Immunology. 202(11). 3267–3281. 19 indexed citations
5.
Meek, Paula, et al.. (2018). Chronic obstructive pulmonary disease mortality, a competing risk analysis. The Clinical Respiratory Journal. 12(11). 2598–2605. 9 indexed citations
6.
Polverino, Francesca, María Laucho-Contreras, Hans Petersen, et al.. (2017). A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 195(11). 1464–1476. 58 indexed citations
7.
Mebratu, Yohannes A., Kevin R. Smith, Getahun E. Agga, & Yohannes Tesfaigzi. (2016). Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses. Respiratory Research. 17(1). 75–75. 23 indexed citations
8.
Laucho-Contreras, María, Francesca Polverino, Yohannes Tesfaigzi, et al.. (2016). Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD). Expert Opinion on Therapeutic Targets. 20(7). 869–883. 57 indexed citations
9.
Polverino, Francesca, Melanie Doyle‐Eisele, Jacob D. McDonald, et al.. (2014). A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease. European Respiratory Journal. 44(Suppl 58). P864–P864. 1 indexed citations
10.
Sood, Anil K., Hans Petersen, Paula Meek, & Yohannes Tesfaigzi. (2013). Spirometry and Health Status Worsen with Weight Gain in Obese Smokers but Improve in Normal-Weight Smokers. American Journal of Respiratory and Critical Care Medicine. 189(3). 274–281. 7 indexed citations
11.
Chand, Hitendra S., et al.. (2012). Acute Inflammation Induces Insulin-like Growth Factor-1 to Mediate Bcl-2 and Muc5ac Expression in Airway Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 47(6). 784–791. 20 indexed citations
12.
Leng, Shuguang, Christine A. Stidley, Yushi Liu, et al.. (2011). Genetic Determinants for Promoter Hypermethylation in the Lungs of Smokers: A Candidate Gene-Based Study. Cancer Research. 72(3). 707–715. 21 indexed citations
13.
Belinsky, Steven A., Marcie J. Grimes, Maria A. Picchi, et al.. (2011). Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model. Cancer Research. 71(2). 454–462. 56 indexed citations
14.
Bruse, Shannon, Anil K. Sood, Hans Petersen, et al.. (2011). New Mexican Hispanic Smokers Have Lower Odds of Chronic Obstructive Pulmonary Disease and Less Decline in Lung Function Than Non-Hispanic Whites. American Journal of Respiratory and Critical Care Medicine. 184(11). 1254–1260. 53 indexed citations
15.
Mebratu, Yohannes A., et al.. (2011). Cigarette Smoke Suppresses Bik To Cause Epithelial Cell Hyperplasia and Mucous Cell Metaplasia. American Journal of Respiratory and Critical Care Medicine. 183(11). 1531–1538. 39 indexed citations
16.
Sood, Anil K., Hans Petersen, Christopher M. Blanchette, et al.. (2010). Wood Smoke Exposure and Gene Promoter Methylation Are Associated with Increased Risk for COPD in Smokers. American Journal of Respiratory and Critical Care Medicine. 182(9). 1098–1104. 105 indexed citations
17.
Harris, Jennifer Foster, et al.. (2004). Bcl-2 Sustains Increased Mucous and Epithelial Cell Numbers in Metaplastic Airway Epithelium. American Journal of Respiratory and Critical Care Medicine. 171(7). 764–772. 46 indexed citations
18.
Singh, Shashi Prakash, Edward G. Barrett, Roma Kalra, et al.. (2003). Prenatal Cigarette Smoke Decreases Lung cAMP and Increases Airway Hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine. 168(3). 342–347. 63 indexed citations
19.
Sanctis, George T. De, et al.. (2002). IFN-γ, But Not Fas, Mediates Reduction of Allergen-Induced Mucous Cell Metaplasia by Inducing Apoptosis. The Journal of Immunology. 168(9). 4764–4771. 47 indexed citations
20.
Tesfaigzi, Yohannes, et al.. (2002). Bax is Crucial for IFN-γ-Induced Resolution of Allergen- Induced Mucus Cell Metaplasia. The Journal of Immunology. 169(10). 5919–5925. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth B. Adler Breakdown of academic impact, for papers by H. Marike Boezen Breakdown of academic impact, for papers by Debra J. Romberger Breakdown of academic impact, for papers by George D. Leikauf Breakdown of academic impact, for papers by Thomas J. Mariani Breakdown of academic impact, for papers by Irene H. Heijink Breakdown of academic impact, for papers by Shizu Hayashi Breakdown of academic impact, for papers by Matthias Salathé Breakdown of academic impact, for papers by Tim D. Oury Breakdown of academic impact, for papers by Todd A. Wyatt
Rankless by CCL
2026